EGFR and neoplasm: We find that BCL2L1, which encodes the anti-apoptotic protein BCL-XL, is highly expressed predominantly in tumor cells, where it likely plays a crucial role in tumor cell survival as drug tolerance and acquired resistance to EGFR-TKIs emerge.